Related Experiment Video
Updated: Jun 22, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Systolic and diastolic function in patients with systemic sclerosis
Laura Poanta1, Razvan Dadu, Cristina Tiboc
1University of Medicine and Pharmacy Iuliu Hatieganu, 2nd Medical Department, Cluj Napoca, Romania. laurapoanta@yahoo.com
Insights
Systemic sclerosis (SSc) patients often have preclinical cardiac diastolic dysfunction, detectable through echocardiography. Early identification of this asymptomatic heart disease is crucial for timely intervention and improved patient outcomes.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Symptomatic heart disease in systemic sclerosis (SSc) indicates a poor prognosis.
- Cardiac involvement in SSc can precede clinical symptoms by years.
- Early detection of cardiac dysfunction is vital for managing SSc patients.
Purpose of the Study:
- To evaluate cardiac function in SSc patients using echocardiography.
- To correlate echocardiographic findings with disease severity markers in SSc.
- To identify preclinical cardiac involvement in SSc.
Main Methods:
- Transthoracic echocardiography (TTE) was performed on 20 consecutive SSc patients.
- Two-dimensional, pulsed Doppler, and tissue Doppler imaging (TDI) assessed left ventricular (LV) systolic and diastolic function.
- Echocardiographic measurements were correlated with clinical and serological SSc features.
Main Results:
- No SSc patients exhibited clinical cardiac signs, ECG, or TTE systolic dysfunction.
- Significant differences in LV filling were observed in SSc patients compared to controls (peak A velocity, E/A ratio, E/Ea ratio).
- A correlation was found between Raynaud's phenomenon duration and LV diastolic dysfunction (E/Ea ratio).
Conclusions:
- Cardiac involvement in SSc often presents as preclinical diastolic dysfunction.
- Asymptomatic SSc patients can have treatable diastolic dysfunction requiring close monitoring.
- Echocardiographic assessment is important for detecting early-stage SSc heart disease.
Background:
Clinical and epidemiological findings indicate that symptomatic heart disease in patients with systemic sclerosis (SSc) predicts poor prognosis, but cardiac involvement may occur years before clinical manifestation. The aim of this study was to evaluate the cardiac function in patients with SSc and to correlate the echocardiographic parameters with others that quantify the diseases' severity.
Methods:
Twenty consecutive patients with SSc were investigated with transthoracic echocardiography (TTE). Two dimensional, pulsed Doppler and pulsed tissue Doppler imaging (TDI) techniques were used, in all the patients, to assess the systolic and diastolic function for left ventricle (LV). Correlations were made between echocardiographic measurements and some clinical and serological features of the patients.
Results:
None of the patients had any clinical signs of cardiac involvement, nor ECG or TTE systolic function impairment; there are significant differences between systemic sclerosis patients and control group for peak A velocity (0.75+/-0.22 vs 0.57+/-0.32, P=0.05), E/A ratio (1.14+/-0.22 vs 1.48+/-0.26, P=0.01), E/Ea ratio (8.25+/-1.57 vs 7+/-2.2, P=0.05), which account for filling impairment of LV. There are also significant correlations between some other parameters, like the mean duration of Raynaud's phenomenon and E/Ea ratio (r=0.48, P<0.05).
Conclusions:
The analysis of SSc heart disease, mainly at a preclinical level, is important in all the cases as an asymptomatic patient may have diastolic dysfunction which can be treated and should be closely observed.
More Related Videos
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction